Statins And GI Flashcards
(112 cards)
PCSK9 Inhibitors
Decreases LDL by 60%
Side effects:
Hypersensitivity rxs, possibly neurocognitive events
Evolocumlab
Alirocumab
Decreasing incidence of heart disease
the longer and lower the reduction in circulating LDL-C, the lower the incidence of CHD
Lipoproteins in the gut versus liver
Gut = chylomicrons - LDL and TG Liver = VLDL - LDL and TG
Coronary Artery Disease Risk Factors
High TG High cholesterol High BP Smoking Gender/age/family hx
Drugs that decrease LDL-cholesterol -> heart disease
What is the RLS in cholesterol synthesis?
Enzyme HMG CoA reductase
HMG CoA -> mevalonate
What do LDL receptors in the liver control?
The production and catabolism of plasma LDL
VLDL -> IDL -> LDL
SREBP
Transcription factor = the master regulator of cholesterol levels in cells
In a low-cholesterol diet = SREBP is ACTIVE
In a high-cholesterol diet = SREBP is INACTIVE
When SREBP is active under conditions of low cholesterol diet…
Increase in cholesterol biosynthesis
Increase in receptor mediated LDL-endocytosis from plasma
Decrease plasma LDL
When SREBP is inactive under conditions of low cholesterol diet…
Decrease in LDL biosynthesis
Decrease in LDL receptors
Plasma LDL remains high
Statins are best tolerated for treating:
Dyslipidemia
HMG CoA reductase inhibitors (competitive inhibitors)
Statin function:
Inhibit cholesterogenesis
Increased expression of LDL receptor
Increased removal of LDL from the blood (levels decrease 20-55%)
Decreased VLDL production
TG levels decrease
HDL levels slightly increase
What part of the LDL molecule is recognized by the LDL receptor?
ApoB protein on the LDL
SLCO1B1
Gene that encodes for OATP1B1
When mutated, it reduces hepatic uptake of simvastatin acid
PCSK9
Proprotein convertase substilsilin/kexin
Degrades the LDLR
The antibody to PCSK9 (PCSK9-inhibitor) allows the LDLR to be recycled.
What is commonly used with statins to reduce LDL levels in plasma?
Evolucumab (PCSK9 inhibitor)
Ezitimibe
Cholesterol absorption inhibitor in the intestine
When combined with statins = 50-60% decrease
Alone = 19%
What does ezitimbe block?
NPC1L1 = cholesterol transporter in enterocytes
Inhibits cholesterol and plant sterol absorption.
Decreases delivery of cholesterol to the liver, slightly increases HDL
Increases expression of hepatic LDL receptor
Decreases the cholesterol content of atherogenic particles
Is Ezitimbe well tolerated?
Not systemically well tolerated
Resins
Also known as BAR - bile acid sequestrant resins
Cholestyramine
BAR
Colestipol
BAR
Colesevelam
BAR
Cholate
Bile Salt
Deoxycholate
bile salt